Cognitive behavioral therapy combined with antidepressant effective in treating adolescent OCD
Advance data suggest that cognitive-behavioral therapy is effective only when provided by experienced therapists According to current epidemiological data, approximately 1 in every 200 young people suffering from obsessive-compulsive disorder (OCD). OCD patients with obsessive thoughts of bad things can happen (obsessions) and repetitive actions, destructive behaviors (compulsions) as a means to deal with those thoughts. OCD can cripple your life, stop learning, and drive a wedge through their families.Team of researchers at Duke University Medical Center have developed a scientifically conclusive treatment combination - with the cognitive-behavioral therapy (CBT) and commonly prescribed antidepressants - to help pediatric patients overcome OCD. Their results - a study of
five years - can be found in the October 27 issue of the Journal of American Medical Association (JAMA). Edna B.Co-Principal Investigator for the component Penns The Pediatric OCD Treatment Study (POTS) says: This survey shows that children diagnosed better with OCD on a combination of Zoloft and CBT, as compared with placebo and either respond alone treatment, but in. Penn responded place, children just as well alone and combination therapy CBT. Zoloft (sertraline) is a commonly prescribed selective serotonin reuptake inhibitors (SSRIs), which causes its effects by increasing the activity of the brain serotnin.
Abandonment of the constraints of implementation in order to know their fears are exaggerated or unrealistic. This is the first study to evaluate the
efficacy of combination treatment in pediatric patients. One hundred twelve children aged seven to 17 years participated in pots. Patients were randomized to CBT over sertraline, CBT alone, sertraline alone or receive placebo for 12 weeks. The researchers found that the 53rdno symptoms at the end of treatment. For them, only the CBT, 39.3 percent of participants showed less severe symptoms of OCD. Participants in the
Pages: [1] 2 3